Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication
ICD-10 E09.49 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication.
E09.49 refers to diabetes mellitus that is induced by drugs or chemicals, which can lead to various complications, particularly neurological ones. This condition arises when certain medications, such as corticosteroids or antipsychotics, disrupt normal glucose metabolism, resulting in hyperglycemia and subsequent diabetes. Neurological complications may include diabetic neuropathy, which manifests as pain, tingling, or loss of sensation in the extremities, and can significantly impact a patient's quality of life. The presence of other diabetic neurological complications may further complicate management, necessitating a comprehensive treatment approach that includes monitoring HbA1c levels, managing insulin therapy, and addressing the specific neurological symptoms. Effective management is crucial to prevent progression of complications and to maintain optimal glycemic control.
Thorough documentation of diabetes management, including medication history and HbA1c levels.
Patients presenting with new-onset diabetes after starting corticosteroids.
Ensure clear documentation of the relationship between medication and diabetes onset.
Detailed notes on neurological symptoms and their relation to diabetes.
Patients with diabetic neuropathy requiring pain management.
Document the severity and type of neurological symptoms for accurate coding.
Used for follow-up visits for diabetes management.
Document history, examination, and medical decision-making.
Endocrinology may require additional lab results.
Common medications include corticosteroids, antipsychotics, and certain diuretics, which can affect glucose metabolism and insulin sensitivity.
